Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Bio Path Holdings Inc (BPTH)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bio Path's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.710 +0.075    +2.85%
15:27:34 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 98,568
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.500 - 2.780
Bio Path 2.710 +0.075 +2.85%

NASDAQ:BPTH Financials

 
A brief overview of the NASDAQ:BPTH financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Bio Path Holdings Inc over time.

Bio-Path Holdings, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 16.08 million compared to USD 13.87 million a year ago. Basic loss per share from continuing operations was USD 33.63 compared to USD 38.12 a year ago. Diluted loss per share from continuing operations was USD 33.63 compared to USD 38.12 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BPTH Income Statement

Gross margin TTM -
Operating margin TTM 0%
Net Profit margin TTM 0%
Return on Investment TTM -182.29%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue
Gross Profit
Operating Income -3.03 -3.28 -4.24 -5.29
Net Income -3.37 -3.2 -4.23 -5.27

BPTH Balance Sheet

Quick Ratio MRQ 0.55
Current Ratio MRQ 1.6
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 25.62%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 3.22 5.02 6.52 11.1
Total Liabilities 2.78 2.5 1.48 2
Total Equity 0.441 2.52 5.04 9.11

BPTH Cash Flow Statement

Cash Flow/Share TTM -18.68
Revenue/Share TTM -
Operating Cash Flow  -94.76%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -1.81 -2.78 -3.29 -3.65
Cash From Investing Activities
Cash From Financing Activities 0.514 1.69
Net Change in Cash -1.3 -1.09 -3.29 -3.65
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BPTH Comments

Write your thoughts about Bio Path Holdings Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Tyler Philipation
Tyler Philipation Feb 27, 2024 7:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I blame dez nutz for the bpth Split. He’s a monster
Reply
0 0
Report
Mary Hill
Mary Hill Jun 02, 2023 2:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
omg I am loading up 1
Reply
1 0
Report
Faisal Dogar
Faisal Dogar Jun 02, 2023 2:27PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hi
Reply
0 2
Report
Haswdt Rswuntr
Haswdt Rswuntr Oct 10, 2022 4:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Patience is the key
Reply
2 0
Report
sarac mehmet
sarac mehmet Mar 14, 2022 11:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
American stocks fall and make a reverse split, and then fall again from $ 500 to $ 0.95 what does the reverse split do again There's shitty stock market.. BİO PATH a disg ra ceful stock...!!!
Reply
1 1
Report
Ec Pd
Ec Pd Mar 14, 2022 11:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lol sell!!
Reply
0 0
Report
Jose Tajes
Jose Tajes Feb 23, 2021 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why is this the only one green now
Reply
0 0
Report
Khaled Alsarraj
Khaled Alsarraj Feb 23, 2021 2:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Check OCGN
Reply
0 0
Report
Jose Tajes
Jose Tajes Feb 22, 2021 12:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
no thoughts on this
Reply
0 0
Report
Khaled Alsarraj
Khaled Alsarraj Feb 22, 2021 12:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I will hold I think After the FDA approvel it will 🚀🚀🚀
Reply
0 1
Report
dennis felipe
dennis felipe Feb 12, 2021 5:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
just bought some on this dip....🚀🚀🚀 let's go again..
Reply
0 0
Report
Daniel Grippe
Daniel Grippe Feb 11, 2021 2:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
where do we see this going. Got distracted and missed my exit, down 57%
Reply
0 0
Report
Arl Nn
ArlN Feb 11, 2021 2:12PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There might be something by the end of the month
Reply
0 0
Report
Jackson Neve
Jackson Neve Feb 10, 2021 8:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Even if no short squeeze to $700-800 due to its small 4 million shares float. Fundamentally, this stock will gradually move to $30-35 by 2022 after getting awarded the patent for their DNAbilize. This company really have the potential as it has hit $700-800 before. Then it has 2 stock splits 1:10 and then 1:20, so now is consider early bird accumulation phase. We will see it go above $30 by end of the week.
Reply
4 2
Report
Gregory Aizenberg
Gregory Aizenberg Feb 10, 2021 8:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Saxo bank reports year average price target 10$. Company has 9 employees. Market cap. 53.5M. do you know why yesterday the price jumped onto 24$?
Reply
0 0
Report
Eugenio Basilici
Eugenio Basilici Feb 10, 2021 12:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🔴 Breaking: $IGC a cannabis stock trading at 3$ now warming up....
Reply
0 0
Report
Frank Thrana
Frank Thrana Feb 10, 2021 12:35PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hvis market?
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email